Department of Neurology, Walton Centre for Neurology and Neurosurgery, Lower Lane, Fazakerley, Liverpool, L9 7LJ, UK.
Mult Scler. 2013 Apr;19(4):502-5. doi: 10.1177/1352458512457840. Epub 2012 Aug 23.
The determination of the minimum clinically important difference (MCID) is an important aspect of scale development. The Neurological Fatigue Index for multiple sclerosis (NFI-MS) was administered before and after expected change or stability in fatigue in 208 multiple sclerosis (MS) patients. The overall change scores of the NFI-MS accorded with perceived direction of change; importantly, no change was seen when none was perceived. Using the interval level NFI-MS scores, the largest MCID equated to 2.49 points on the Summary scale, 2.36 points on the Physical scale, 0.84 points on the Cognitive scale, 0.97 on the Diurnal Sleep scale and 1.95 on the Nocturnal Sleep scale. Our conclusion is that the NFI-MS responds as expected to changes in fatigue and has desirably small MCID scores.
确定最小临床重要差异(MCID)是量表开发的一个重要方面。在 208 例多发性硬化症(MS)患者的疲劳预期变化或稳定前后,使用多发性硬化症疲劳量表(NFI-MS)进行了评估。NFI-MS 的总体变化评分与感知的变化方向一致;重要的是,当没有感知到变化时,没有看到变化。使用区间水平的 NFI-MS 评分,最大的 MCID 相当于综合量表上的 2.49 分,物理量表上的 2.36 分,认知量表上的 0.84 分,日间睡眠量表上的 0.97 分,夜间睡眠量表上的 1.95 分。我们的结论是,NFI-MS 对疲劳变化的反应符合预期,且具有理想的较小 MCID 评分。